论文部分内容阅读
难治性白血病按常规方法治疗多难以奏效 ,而单纯采用强烈的联合化疗方案 ,缓解率也较低。疗效差的原因与白血病细胞产生多药耐药基因有关。现将作者应用环孢素 A(Cs A)逆转难治性白血病多药耐药基因 (mdrl)的临床研究报告如下。1 材料与方法1.1 一般资料 门诊及住院患者共 3
Refractory leukemia treatment by conventional methods more difficult to work, and simply using a strong combination of chemotherapy, the response rate is lower. The reasons for poor efficacy and leukemia cells produce multidrug resistance genes. Now the author of cyclosporin A (Cs A) reversal of refractory leukemia multidrug resistance gene (mdrl) clinical research report is as follows. 1 Materials and Methods 1.1 General Information Outpatient and inpatient total 3